Article Details
Retrieved on: 2025-08-03 06:56:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Schonfeld Strategic Advisors LLC owned approximately 3.97% of Galmed Pharmaceuticals at the end of the most recent quarter. Institutional investors ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here